These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 37342097)

  • 1. A Case of Abdominal Perforation in a COVID+ Patient Treated With Tocilizumab and Corticosteroids.
    Chaudhry B; Alekseyev K; Didenko L; Chaudhry M
    Clin Med Insights Case Rep; 2023; 16():11795476231173870. PubMed ID: 37342097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Phase I/II Clinical Trial to evaluate the efficacy of baricitinib to prevent respiratory insufficiency progression in onco-hematological patients affected with COVID19: A structured summary of a study protocol for a randomised controlled trial.
    Moreno-González G; Mussetti A; Albasanz-Puig A; Salvador I; Sureda A; Gudiol C; Salazar R; Marin M; Garcia M; Navarro V; de la Haba Vaca I; Coma E; Sanz-Linares G; Dura X; Fontanals S; Serrano G; Cruz C; Mañez R
    Trials; 2021 Feb; 22(1):116. PubMed ID: 33546739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tocilizumab and Baricitinib for Recovery From Acute Exacerbation of Combined Pulmonary Fibrosis and Emphysema Secondary to COVID-19 Infection: A Case Report.
    Kai Y; Matsuda M; Suzuki K; Kasamatsu T; Kajita A; Uno K; Muro S
    Cureus; 2022 Mar; 14(3):e23411. PubMed ID: 35481309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sarilumab versus standard of care for the early treatment of COVID-19 pneumonia in hospitalized patients: SARTRE: a structured summary of a study protocol for a randomised controlled trial.
    Caballero Bermejo AF; Ruiz-Antorán B; Fernández Cruz A; Diago Sempere E; Callejas Díaz A; Múñez Rubio E; Avendaño-Solá C; Ramos Martínez A; Sancho López A;
    Trials; 2020 Sep; 21(1):794. PubMed ID: 32938496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Success rate of Remdesivir, Convalescent Plasma, and Tocilizumab in moderate to severe Covid-19 pneumonia: our experience in a tertiary care center.
    Mohanty B; Sunder A; Satyanarayan B; Kumar M; Shukla R; Ahmed A
    J Family Med Prim Care; 2021 Nov; 10(11):4236-4241. PubMed ID: 35136795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tocilizumab for the Treatment of COVID-19-Induced Cytokine Storm and Acute Respiratory Distress Syndrome: A Case Series From a Rural Level 1 Trauma Center in Western Pennsylvania.
    Suresh K; Figart M; Formeck S; Mehmood T; Abdel Salam M; Bassilly D
    J Investig Med High Impact Case Rep; 2021; 9():23247096211019557. PubMed ID: 34105382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cryptococcal Meningoencephalitis During Convalescence From Severe COVID-19 Pneumonia.
    Thota DR; Ray B; Hasan M; Sharma K
    Neurohospitalist; 2022 Jan; 12(1):96-99. PubMed ID: 34950394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tocilizumab and remdesivir in hospitalized patients with severe COVID-19 pneumonia: a randomized clinical trial.
    Rosas IO; Diaz G; Gottlieb RL; Lobo SM; Robinson P; Hunter BD; Cavalcante AW; Overcash JS; Hanania NA; Skarbnik A; Garcia-Diaz J; Gordeev I; Carratalà J; Gordon O; Graham E; Lewin-Koh N; Tsai L; Tuckwell K; Cao H; Brainard D; Olsson JK
    Intensive Care Med; 2021 Nov; 47(11):1258-1270. PubMed ID: 34609549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COVID-19: A Review of Potential Treatments (Corticosteroids, Remdesivir, Tocilizumab, Bamlanivimab/Etesevimab, and Casirivimab/Imdevimab) and Pharmacological Considerations.
    Nhean S; Varela ME; Nguyen YN; Juarez A; Huynh T; Udeh D; Tseng AL
    J Pharm Pract; 2023 Apr; 36(2):407-417. PubMed ID: 34597525
    [No Abstract]   [Full Text] [Related]  

  • 10. Colonic Ileus, Distension, and Ischemia Due to COVID-19-Related Colitis: A Case Report and Literature Review.
    Shaikh DH; Patel H; Makker J; Badipatla K; Chilimuri S
    Cureus; 2021 Feb; 13(2):e13236. PubMed ID: 33728185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of the Addition of Baricitinib to Standard of Care Including Tocilizumab and Corticosteroids on Mortality and Safety in Severe COVID-19.
    Masiá M; Padilla S; García JA; García-Abellán J; Navarro A; Guillén L; Telenti G; Mascarell P; Botella Á; Gutiérrez F
    Front Med (Lausanne); 2021; 8():749657. PubMed ID: 34820393
    [No Abstract]   [Full Text] [Related]  

  • 12. Report of a combination of remdesivir, intravenous methylprednisolone pulse, and tocilizumab for severe coronavirus disease: 20-case series at a single institution.
    Ichiyama T; Komatsu M; Wada Y; Hanaoka M
    Respir Investig; 2022 Jul; 60(4):604-606. PubMed ID: 35501265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Initiation of Tocilizumab or Baricitinib Were Associated With Comparable Clinical Outcomes Among Patients Hospitalized With COVID-19 and Treated With Dexamethasone.
    Wong CKH; Lau KTK; Au ICH; Xiong X; Chung MSH; Leung BYC; Lau EHY; Cowling BJ
    Front Pharmacol; 2022; 13():866441. PubMed ID: 35707401
    [No Abstract]   [Full Text] [Related]  

  • 14. Severe COVID-19 Pneumonia Treated by Intensive Immune Suppression Therapy With a Combination of Steroid Pulse and Tocilizumab Followed by a Tapering Dose of Steroid Therapy During the Delta (B.1.617.2) Variant Outbreak: A Successfully Treated Case.
    Muramatsu KI; Ishikawa K; Komatsu A; Jitsuiki K; Yanagawa Y
    Cureus; 2021 Nov; 13(11):e19340. PubMed ID: 34909301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tocilizumab Versus Baricitinib in Patients Hospitalized With COVID-19 Pneumonia and Hypoxemia: A Multicenter Retrospective Cohort Study.
    Roddy J; Wells D; Schenck K; Santosh S; Santosh S
    Crit Care Explor; 2022 May; 4(5):e0702. PubMed ID: 35783551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of Baricitinib in Combination With Remdesivir and Steroid in COVID-19 Treatment: A Multicenter Retrospective Study.
    So JM; Umeh C; Noriega S; Stratton E; Aseri M; Gupta RC
    Cureus; 2021 Dec; 13(12):e20620. PubMed ID: 35106192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tocilizumab and steroid treatment in patients with COVID-19 pneumonia.
    Mikulska M; Nicolini LA; Signori A; Di Biagio A; Sepulcri C; Russo C; Dettori S; Berruti M; Sormani MP; Giacobbe DR; Vena A; De Maria A; Dentone C; Taramasso L; Mirabella M; Magnasco L; Mora S; Delfino E; Toscanini F; Balletto E; Alessandrini AI; Baldi F; Briano F; Camera M; Dodi F; Ferrazin A; Labate L; Mazzarello G; Pincino R; Portunato F; Tutino S; Barisione E; Bruzzone B; Orsi A; Schenone E; Rosseti N; Sasso E; Da Rin G; Pelosi P; Beltramini S; Giacomini M; Icardi G; Gratarola A; Bassetti M
    PLoS One; 2020; 15(8):e0237831. PubMed ID: 32817707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prospective, randomised, double blind placebo-controlled trial to evaluate the efficacy and safety of tocilizumab in patients with severe COVID-19 pneumonia (TOC-COVID): A structured summary of a study protocol for a randomised controlled trial.
    Rilinger J; Kern WV; Duerschmied D; Supady A; Bode C; Staudacher DL; Wengenmayer T
    Trials; 2020 Jun; 21(1):470. PubMed ID: 32493514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-Dose Tocilizumab With High-Dose Corticosteroids in Patients Hospitalized for COVID-19 Hypoxic Respiratory Failure Improves Mortality Without Increased Infection Risk.
    Brosnahan SB; Chen XJC; Chung J; Altshuler D; Islam S; Thomas SV; Winner MD; Greco AA; Divers J; Spiegler P; Sterman DH; Parnia S
    Ann Pharmacother; 2022 Mar; 56(3):237-244. PubMed ID: 34180274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of tocilizumab, remdesivir, and high-dose methylprednisolone prevents intubation in an ESRD patient with COVID-19 pneumonia.
    Judge R; Kolaski S; Qadeer F
    SAGE Open Med Case Rep; 2022; 10():2050313X211069023. PubMed ID: 35035974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.